What Is PET?

PET, or positron emission tomography, is a nuclear medicine imaging technique that produces three-dimensional maps of metabolic and physiological processes within the body by detecting gamma rays emitted following the annihilation of positrons released by a radioactive tracer. Unlike anatomical modalities such as X-ray or CT, PET reveals functional information: how tissue consumes glucose, how receptors bind to specific molecules, or how blood perfuses an organ. This distinction makes PET a central tool in oncology, cardiology, and neuroscience.

The technique emerged from physics research in the 1970s, building on earlier work in nuclear medicine and scintillation detection. PET draws on nuclear physics, radiochemistry, signal processing, and tomographic reconstruction, placing it at the intersection of physics and clinical medicine.

Physics of Detection

PET imaging depends on the annihilation reaction between a positron and an electron. When a positron-emitting radioisotope decays inside the body, the emitted positron travels a short distance before annihilating with a nearby electron, producing two 511 keV gamma photons that travel in opposite directions. A ring of scintillator detectors surrounding the patient records these photon pairs as coincidence events, each defining a line in space along which the decay occurred. The spatial resolution and sensitivity of a PET scanner depend on the scintillator material, detector geometry, and the electronics timing resolution. An authoritative overview of PET physics and detector design appears in the Mathematics and Physics of Emerging Biomedical Imaging published by the National Academies Press.

Radiotracers

The clinical information that PET provides depends entirely on the radiotracer chosen. Fluorodeoxyglucose labeled with fluorine-18 (FDG) is by far the most commonly used tracer, exploiting the elevated glucose uptake of rapidly dividing cancer cells to highlight tumors. Other radiotracers target dopamine receptors in Parkinson's disease research, amyloid plaques in Alzheimer's disease staging, and myocardial perfusion in cardiac assessment. The radiochemistry underlying tracer synthesis is complex: isotopes with short half-lives, such as carbon-11 (20 minutes) or fluorine-18 (110 minutes), must be produced in an on-site or nearby cyclotron and incorporated into biological molecules quickly. Research on new tracer designs is reviewed in Nature Communications' survey of radiochemistry for PET.

Image Reconstruction

Raw PET data consist of millions of coincidence event records. Converting these into a usable volumetric image requires tomographic reconstruction algorithms that account for photon scatter, random coincidences, and attenuation through tissue of varying density. Filtered back-projection was the standard approach in early scanners; iterative algorithms such as MLEM (maximum likelihood expectation maximization) and its accelerated variant OSEM (ordered subsets EM) became dominant from the 1990s onward because they produce lower noise at equivalent dose. Time-of-flight PET, now standard in high-end clinical systems, uses sub-nanosecond timing to constrain the annihilation location along each line of response, improving image quality significantly. Research on advances in reconstruction for combined systems is covered in PMC's review of image reconstruction for PET/CT scanners. The IEEE Xplore paper on improving PET with guided filtering illustrates ongoing signal-processing research in this area.

Applications

PET has applications in a range of fields, including:

• Oncology: tumor detection, staging, and treatment response monitoring
• Neurology: assessment of Alzheimer's disease, epilepsy, and movement disorders
• Cardiology: evaluation of myocardial viability and perfusion
• Drug development: pharmacokinetic studies and receptor occupancy measurements
• Radiation therapy planning in combination with CT or MR imaging